The effect of nitric oxide on the production of prostaglandin E2 by hydroxyapatite-stimulated a human osteoblast (HOS) cell line

Biomed Pharmacother. 2006 May;60(4):147-51. doi: 10.1016/j.biopha.2006.02.008. Epub 2006 Mar 24.

Abstract

The aim of the present study was to determine the effect of nitric oxide (NO) on the production of prostaglandin E2 (PGE2) by a human osteoblast cell line (HOS cells) stimulated with hydroxyapatite. Cells were cultured on the HA surfaces with or without the presence of NO donors (SNAP and NAP) for 3 days. The effect of NO scavenger, carboxy PTIO, or endothelial nitric oxide synthase (eNOS) inhibitor, L-NIO, was assessed by adding this scavenger in the cultures of HA-stimulated HOS cells with or without the presence of SNAP. Furthermore, HOS cells were pre-treated with anti-human integrin alphaV antibody, indomethacin, a non-specific inhibitor, aspirin, a COX-1 inhibitor, or nimesulide, a COX-2 inhibitor, prior to culturing on HA surfaces with or without the presence of SNAP. The levels of PGE2 were determined from the 3 day culture supernatants. The results showed that the production of PGE2 by HA-stimulated HOS cells was augmented by SNAP. Carboxy PTIO suppressed but L-NIO only partially inhibited the production of PGE2 by HA-stimulated HOS cells with or without the presence of exogenous NO. Pre-treatment of the cells with anti-human integrin alphaV antibody, indomethacin or nimesulide but not aspirin suppressed the production of PGE2 by HA-stimulated HOS cells with or without the presence of NO. Therefore, the results of the present study suggest that NO may up-regulate the production of PGE2 by augmenting the COX-2 pathway initiated by the binding between HOS cell-derived integrin alphaV and HA surface.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Dinoprostone / metabolism*
  • Durapatite / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Integrin alphaV
  • Nitric Oxide / pharmacology*
  • Nitric Oxide Donors / pharmacology
  • Ornithine / analogs & derivatives*
  • Ornithine / pharmacology
  • Osteoblasts / drug effects*
  • S-Nitroso-N-Acetylpenicillamine / pharmacology

Substances

  • Enzyme Inhibitors
  • Integrin alphaV
  • Nitric Oxide Donors
  • Nitric Oxide
  • N(G)-iminoethylornithine
  • S-Nitroso-N-Acetylpenicillamine
  • Durapatite
  • Ornithine
  • Dinoprostone